Quantitative Analysis and Determination of Molecular Weight of siRNA Type Oligonucleotides by LCMS™-8060
Applications | 2020 | ShimadzuInstrumentation
Nucleic acid therapeutics are gaining prominence due to their ability to modulate gene expression at the RNA level. Among these, siRNA oligonucleotides require precise quantification and mass verification during drug development and quality control. Sensitive and accurate analysis of these molecules is crucial for evaluating pharmacokinetics, ensuring batch consistency and supporting regulatory compliance.
This study aimed to demonstrate a reliable method for quantitative analysis and molecular weight determination of double-strand siRNA oligonucleotides using a Shimadzu LCMS-8060 triple quadrupole mass spectrometer. Key goals included establishing calibration curves in a femtomole range and validating molecular weight measurements via spectral deconvolution.
A reverse phase ion pair LC method was developed on a Nexera system equipped with a C18 column (100 × 2.1 mm, 1.7 µm). The mobile phase comprised 200 mM 1,1,1,3,3,3-hexafluoro-2-propanol with 7.5 mM triethylamine in water and methanol. A linear gradient from 4 % to 20 % methanol over 8 minutes at 75 °C and a flow rate of 0.2 mL/min was applied.
Instrumentation
Selected ion monitoring provided linear calibration from 1 to 10 000 fmol for both sense and antisense oligonucleotides. Limits of detection and quantitation were 1 fmol and 5 fmol, respectively, corresponding to approximately 3 ng/mL for a 10 µL injection. Coefficients of determination exceeded 0.995. Multiple reaction monitoring was less sensitive, failing to detect the 5 fmol calibration point. Spectral deconvolution using LabSolutions software yielded average molecular weights of 6645.6 Da for the antisense strand and 6667.1 Da for the sense strand, with mass errors below 2 Da.
This workflow enables ultra-sensitive quantitation of siRNA oligonucleotides in a simple SIM experiment, facilitating pharmacokinetic studies and manufacturing quality control. The ability to determine molecular weight accurately with a triple quadrupole instrument expands its utility beyond quantitation, reducing the need for additional high-resolution measurements.
Advances in ion pair reagents and chromatographic media may further enhance separation efficiency. Emerging high-sensitivity detectors and optimized ESI sources could push detection limits into the attomole range. Integration of automated data processing and real-time deconvolution tools will streamline workflows for genomic medicine applications. The combination of high-throughput LC–MS platforms with bioinformatics is poised to accelerate oligonucleotide therapeutic development.
The presented SIM-based LCMS-8060 method offers robust quantitation and reliable molecular weight determination of siRNA oligonucleotides in the femtomole range. It provides a cost-effective alternative to high-resolution instruments for both analytical laboratories and the pharmaceutical industry.
M. Yamada Quantitative Analysis and Determination of Molecular Weight of siRNA Type Oligonucleotides by LCMS-8060 Shimadzu Application News No C219 First Edition Aug 2020
LC/MS, LC/MS/MS, LC/QQQ
IndustriesClinical Research
ManufacturerShimadzu
Summary
Importance of the Topic
Nucleic acid therapeutics are gaining prominence due to their ability to modulate gene expression at the RNA level. Among these, siRNA oligonucleotides require precise quantification and mass verification during drug development and quality control. Sensitive and accurate analysis of these molecules is crucial for evaluating pharmacokinetics, ensuring batch consistency and supporting regulatory compliance.
Objectives and Study Overview
This study aimed to demonstrate a reliable method for quantitative analysis and molecular weight determination of double-strand siRNA oligonucleotides using a Shimadzu LCMS-8060 triple quadrupole mass spectrometer. Key goals included establishing calibration curves in a femtomole range and validating molecular weight measurements via spectral deconvolution.
Methodology and Instrumentation
A reverse phase ion pair LC method was developed on a Nexera system equipped with a C18 column (100 × 2.1 mm, 1.7 µm). The mobile phase comprised 200 mM 1,1,1,3,3,3-hexafluoro-2-propanol with 7.5 mM triethylamine in water and methanol. A linear gradient from 4 % to 20 % methanol over 8 minutes at 75 °C and a flow rate of 0.2 mL/min was applied.
Instrumentation
- LC system Nexera with C18 column
- LCMS-8060 triple quadrupole mass spectrometer
- ESI source in negative ion mode
- SIM acquisition at m/z 1659.9 and 1666.0
- Q3 scan range m/z 500–1800
Main Results and Discussion
Selected ion monitoring provided linear calibration from 1 to 10 000 fmol for both sense and antisense oligonucleotides. Limits of detection and quantitation were 1 fmol and 5 fmol, respectively, corresponding to approximately 3 ng/mL for a 10 µL injection. Coefficients of determination exceeded 0.995. Multiple reaction monitoring was less sensitive, failing to detect the 5 fmol calibration point. Spectral deconvolution using LabSolutions software yielded average molecular weights of 6645.6 Da for the antisense strand and 6667.1 Da for the sense strand, with mass errors below 2 Da.
Benefits and Practical Applications of the Method
This workflow enables ultra-sensitive quantitation of siRNA oligonucleotides in a simple SIM experiment, facilitating pharmacokinetic studies and manufacturing quality control. The ability to determine molecular weight accurately with a triple quadrupole instrument expands its utility beyond quantitation, reducing the need for additional high-resolution measurements.
Future Trends and Opportunities
Advances in ion pair reagents and chromatographic media may further enhance separation efficiency. Emerging high-sensitivity detectors and optimized ESI sources could push detection limits into the attomole range. Integration of automated data processing and real-time deconvolution tools will streamline workflows for genomic medicine applications. The combination of high-throughput LC–MS platforms with bioinformatics is poised to accelerate oligonucleotide therapeutic development.
Conclusion
The presented SIM-based LCMS-8060 method offers robust quantitation and reliable molecular weight determination of siRNA oligonucleotides in the femtomole range. It provides a cost-effective alternative to high-resolution instruments for both analytical laboratories and the pharmaceutical industry.
Reference
M. Yamada Quantitative Analysis and Determination of Molecular Weight of siRNA Type Oligonucleotides by LCMS-8060 Shimadzu Application News No C219 First Edition Aug 2020
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Oligonucleotide Therapeutics Solution Guide
2025|Shimadzu|Guides
C10G-E097 Oligonucleotide Therapeutics Solution Guide Types and Characteristics of Oligonucleotide Therapeutics Oligonucleotide therapeutics are nucleic acid polymers generally comprised of a few to several dozen bases However, it is a practical problem that oligonucleotide therapeutics are degraded and excreted rapidly…
Key words
excision, excisionunprotected, unprotecteddds, ddscharacteristic, characteristicindex, indexoligomer, oligomerpharmacokinetics, pharmacokineticsquality, qualitycontrol, controloligonucleotide, oligonucleotidesynthesis, synthesispurification, purificationmodification, modificationtorast, torastanalysis
Determination of Molecular Mass and Quantification of Oligonucleotide Therapeutics Using Quadrupole Time-of-Flight Mass Spectrometer LCMS™-9030
2020|Shimadzu|Applications
Application News No. C215 LC-MS Determination of Molecular Mass and Quantification of Oligonucleotide Therapeutics Using Quadrupole Time-of-Flight Mass Spectrometer LCMS™-9030 Overview Oligonucleotide therapeutics are synthetic oligonucleotides that demonstrate their medical efficacy through binding to target genes or target proteins…
Key words
oligonucleotide, oligonucleotidemass, masstherapeutics, therapeuticsusing, usingshimadzu, shimadzuqtof, qtofデコンボリューションスペクトル, デコンボリューションスペクトルcurve, curvedeconvolution, deconvolutionquadrupole, quadrupoleデフォルト, デフォルトflow, flownews, newscalibration, calibrationanalysis
Verification of Quantitativity and Confirmation of Molecular Weight of Oligonucleotide therapeutics Using LCMS™-8060
2020|Shimadzu|Applications
Application News No. C231 Liquid Chromatography Mass Spectrometry Verification of Quantitativity and Confirmation of Molecular Weight of Oligonucleotide therapeutics Using LCMS™-8060 Overview Sample Oligonucleotide therapeutics are synthetic oligonucleotides which demonstrate medical efficacy by bonding with target genes or…
Key words
multivalent, multivalentdeconvolution, deconvolutiontherapeutics, therapeuticsoligonucleotide, oligonucleotidespectrum, spectrumquantitativity, quantitativitynews, newsflow, flowgas, gasmass, massefficacy, efficacyoligonucleotides, oligonucleotidesbonding, bondingmedical, medicaldeconvoluted
Qualification and Quantitation of Phosphorothioate Oligonucleotides Using a Quadrupole-Time-of-Flight Mass Spectrometer
2020|Shimadzu|Posters
WP 459 Qualification and Quantitation of Phosphorothioate Oligonucleotides Using a Quadrupole-Time-of-Flight Mass Spectrometer Noriko Kato, Yusuke Inohana, Tairo Ogura, Masaki Yamada, Toshiya Matsubara Shimadzu Corporation. 1, Nishinokyo-Kuwabaracho Nakagyo-ku, Kyoto 604–8511, Japan 3. Methods 1. Overview The purpose of this study…
Key words
mipomersen, mipomersenphosphorothioate, phosphorothioateoligonucleotide, oligonucleotidelna, lnaanalogues, analoguesmonoisotopic, monoisotopicspectrum, spectrumome, omeoligonucleotides, oligonucleotidescharge, chargemass, massdeconvoluted, deconvolutedquantitation, quantitationusing, usingresolution